APPLICATION
NDA010418
TYPE
NDA
LATEST ACTION
1985-10-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
XYLOCAINEDiscontinued
LIDOCAINE HYDROCHLORIDE 1.5% · INJECTABLE · INJECTION
XYLOCAINEDiscontinued
LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
XYLOCAINEDiscontinued
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION
XYLOCAINE W/ EPINEPHRINEDiscontinued
EPINEPHRINE 0.005MG/ML, LIDOCAINE HYDROCHLORIDE 2% · INJECTABLE · INJECTION
XYLOCAINE W/ EPINEPHRINEDiscontinued
EPINEPHRINE 0.005MG/ML, LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION
XYLOCAINE W/ EPINEPHRINEDiscontinued
EPINEPHRINE 0.005MG/ML, LIDOCAINE HYDROCHLORIDE 1.5% · INJECTABLE · INJECTION
Approval history
1985-10-17Labeling · Supplement 4AP
1982-03-25Manufacturing (CMC) · Supplement 5 · standardAP
1981-02-09Labeling · Supplement 3AP
1975-07-16Manufacturing (CMC) · Supplement 2 · standardAP
1972-11-28Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.